121 related articles for article (PubMed ID: 10446454)
1. Apoptosis-promoting gene (bax) transfer potentiates sensitivity of squamous cell carcinoma to cisplatin in vitro and in vivo.
Sugimoto C; Fujieda S; Seki M; Sunaga H; Fan GK; Tsuzuki H; Borner C; Saito H; Matsukawa S
Int J Cancer; 1999 Sep; 82(6):860-7. PubMed ID: 10446454
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
[TBL] [Abstract][Full Text] [Related]
3. Combination effect of adenovirus-mediated pro-apoptotic bax gene transfer with cisplatin or paclitaxel treatment in ovarian cancer cell lines.
Tsuruta Y; Mandai M; Konishi I; Kuroda H; Kusakari T; Yura Y; Hamid AA; Tamura I; Kariya M; Fujii S
Eur J Cancer; 2001 Mar; 37(4):531-41. PubMed ID: 11267864
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of chemotherapeutic agents induced-apoptosis associated with activation of c-Jun N-terminal kinase 1 and caspase 3 (CPP32) in bax-transfected gastric cancer cells.
Kim R; Ohi Y; Inoue H; Toge T
Anticancer Res; 2000; 20(1A):439-44. PubMed ID: 10769693
[TBL] [Abstract][Full Text] [Related]
5. Regulation of apoptosis reduction in the cisplatin-resistant A431 cell line by Bcl-2 and CPP32.
Mese H; Sasaki A; Alcalde RE; Nakayama S; Matsumura T
Chemotherapy; 2000; 46(1):69-76. PubMed ID: 10601800
[TBL] [Abstract][Full Text] [Related]
6. Mn-SOD antisense upregulates in vivo apoptosis of squamous cell carcinoma cells by anticancer drugs and gamma-rays regulating expression of the BCL-2 family proteins, COX-2 and p21.
Ueta E; Yoneda K; Kimura T; Tatemoto Y; Doi S; Yamamoto T; Osaki T
Int J Cancer; 2001 Nov; 94(4):545-50. PubMed ID: 11745442
[TBL] [Abstract][Full Text] [Related]
7. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment of cisplatin and overexpression of caspase-activated deoxyribonuclease (CAD) promotes apoptosis in vitro and in vivo.
Kimura Y; Sugimoto C; Matsukawa S; Sunaga H; Igawa H; Yamamoto H; Ito T; Saito H; Fujieda S
Oral Oncol; 2004 Apr; 40(4):390-9. PubMed ID: 14969818
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of expression levels of bax, bcl-2, and survivin in cancer cells during cisplatin treatment.
Ikeguchi M; Nakamura S; Kaibara N
Oncol Rep; 2002; 9(5):1121-6. PubMed ID: 12168083
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Bax enhances antitumor activity of chemotherapeutic agents in human head and neck squamous cell carcinoma.
Guo B; Cao S; Tóth K; Azrak RG; Rustum YM
Clin Cancer Res; 2000 Feb; 6(2):718-24. PubMed ID: 10690558
[TBL] [Abstract][Full Text] [Related]
11. CXCR4 enhances cisplatin resistance of human tongue squamous cell carcinoma.
Zhuang XM; Zhou B
J Oral Pathol Med; 2019 Feb; 48(2):122-128. PubMed ID: 30554431
[TBL] [Abstract][Full Text] [Related]
12. Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomas.
Taguchi T; Kato Y; Baba Y; Nishimura G; Tanigaki Y; Horiuchi C; Mochimatsu I; Tsukuda M
Oncol Rep; 2004 Feb; 11(2):421-6. PubMed ID: 14719078
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of antitumor effect by intratumoral administration of bax gene in combination with anticancer drugs in gastric cancer.
Kim R; Minami K; Nishimoto N; Toge T
Int J Oncol; 2001 Feb; 18(2):363-7. PubMed ID: 11172605
[TBL] [Abstract][Full Text] [Related]
14. Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo.
Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
Cell Physiol Biochem; 2016; 39(1):242-52. PubMed ID: 27336949
[TBL] [Abstract][Full Text] [Related]
15. Bax induction activates apoptotic cascade via mitochondrial cytochrome c release and Bax overexpression enhances apoptosis induced by chemotherapeutic agents in DLD-1 colon cancer cells.
Kobayashi T; Sawa H; Morikawa J; Zhang W; Shiku H
Jpn J Cancer Res; 2000 Dec; 91(12):1264-8. PubMed ID: 11123425
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Bax in oral SCC in relation to antitumor effects of chemotherapy.
Takemura K; Noguchi M; Ogi K; Tokino T; Kubota H; Miyazaki A; Kohama G; Hiratsuka H
J Oral Pathol Med; 2005 Feb; 34(2):93-9. PubMed ID: 15641988
[TBL] [Abstract][Full Text] [Related]
17. MiR-222 targeted PUMA to improve sensitization of UM1 cells to cisplatin.
Jiang F; Zhao W; Zhou L; Liu Z; Li W; Yu D
Int J Mol Sci; 2014 Dec; 15(12):22128-41. PubMed ID: 25474084
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of bax sensitizes breast cancer MCF-7 cells to cisplatin and etoposide.
Sakakura C; Sweeney EA; Shirahama T; Igarashi Y; Hakomori S; Tsujimoto H; Imanishi T; Ogaki M; Ohyama T; Yamazaki J; Hagiwara A; Yamaguchi T; Sawai K; Takahashi T
Surg Today; 1997; 27(7):676-9. PubMed ID: 9306577
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the chemosensitivity of head and neck cancer cells based on the diverse function of mutated-p53.
Shinagawa Y; Kawamata H; Omotehara F; Nakashiro K; Hoque MO; Furihata T; Horiuchi H; Imai Y; Fujimori T; Fujibayashi T
Int J Oncol; 2003 Feb; 22(2):383-9. PubMed ID: 12527938
[TBL] [Abstract][Full Text] [Related]
20. In vitro establishment of cis-diammine-dichloroplatinum(II) resistant lung cancer cell line and modulation of apoptotic gene expression as a mechanism of resistant phenotype.
Yoon SS; Ahn KS; Kim SH; Shim YM; Kim J
Lung Cancer; 2001; 33(2-3):221-8. PubMed ID: 11551417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
